Top

FOR TRANSLATIONAL RESEARCH IN NUCLEAR MEDICINE

Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.

This more particularly include the GIP ARRONAX, the laboratories CeisamCEMA-OnirisCRCI2NA, LS2NSubatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.

Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.

our publications

  • Brain intratumoural astatine-211 radiotherapy targeting syndecan-1 leads to durable glioblastoma remission and immune memory in female mice, Roncali L, Marionneau-Lambot S, Roy C, Eychenne R, Gouard S, Avril S, et al., eBioMedicine [Internet]. 1 July 2024, https://doi.org/10.1016/j.ebiom.2024.105202

  • Proton-induced reactions for 47Sc (and 46Sc) production: new nuclear cross section measurements on enriched titanium targets, Pupillo G, De Dominicis L, Cisternino S, Esposito J, Campostrini M, Rigato V, et al., J Radioanal Nucl Chem [Internet], 18 avr 2024. https://doi.org/10.1007/s10967-024-09378-w

our news

Our equipments